At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
In Brief
An observational study for Prostate Cancer. Completed, enrolled 1 participant across 1 site.
Detailed Summary
The purpose of this study is to determine the incidence of prostate cancer in men with the BRCa2 gene mutation as an independent indicator for prostate cancer screening.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedJun 2014
Primary CompletionNov 2019
TodayJul 2026
First PostedJun 3, 2014
Enrollment StartMay 1, 2014
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.1 years ago